Search for other papers by H. Nawaz in
Current site
Google Scholar
PubMed
Search for other papers by M. Aslam in
Current site
Google Scholar
PubMed
Search for other papers by T. Rehman in
Current site
Google Scholar
PubMed
Abstract
Hyperbilirubinemia or jaundice has been studied by many researchers because of its diverse causes and potential for toxicity especially in the neonate but to a lesser extent beyond the neonate as well. Several studies have been performed on the normal metabolism and metabolic disorders of bilirubin in last decades of the 20th century. The recent advancement in research and technology facilitated for the researchers to investigate new horizons of the causes and treatment of neonatal hyperbilirubinemia. This review gives a brief introduction to hyperbilirubinemia and jaundice and the recent advancement in the treatment of neonatal hyperbilirubinemia. It reports modifications in the previously used methods and findings of some newly developed ones. At present, ample literature is available discussing the issues regarding hyperbilirubinemia and jaundice, but still more research needs to be done.
-
1.
Hansen TWR. Core concepts: Bilirubin metabolism. NeoReviews 2010; 11(6): e316–e322.
-
2.
Pirone CL. Bilirubin: an animal pigment in the zingiberales and diverse angiosperm orders. FIU Electronic Theses and Dissertations; 2010, vol. 336. https://doi.org/10.25148/etd.FI10122201.
-
3.
Trivin F, Odievre M. Bilirubin metabolism in the newborn. Recent progress. Arch Fr Pediatr 1976; 33(3): 293–304.
-
4.
Porter ML, Dennis MBL. Hyperbilirubinemia in the term newborn. Am Fam Physician 2002; 65(4): 599.
-
5.
Bloomer JR, Risheg H. Bilirubin and porphyrin metabolism. In: Atlas of the liver. Springer; 2004, pp. 1–17.
-
6.
Wang X, Chowdhury JR, Chowdhury NR. Bilirubin metabolism: Applied physiology. Curr Paediatr 2006; 16(1): 70–74.
-
7.
Roy-Chowdhury N, Lu Y, Roy-Chowdhury J. Bilirbuin metabolism. Textb Hepatol Basic Sci Clin Pract 2008; 165–174.
-
8.
Lin Z, Fontaine J, Watchko JF. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics 2008; 122(1): e156–e162.
-
9.
van de Steeg E, Stráneckỳ V, Hartmannová H, Nosková L, Hřebíček M, Wagenaar E, et al. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver. J Clin Invest 2012; 122(2): 519–528.
-
10.
Bosma PJ. Inherited disorders of bilirubin metabolism. J Hepatol 2003; 38(1): 107–117.
-
11.
Memon N, Weinberger BI, Hegyi T, Aleksunes LM. Inherited disorders of bilirubin clearance. Pediatr Res 2016; 79(3): 378–386.
-
12.
Bellarosa C, Bortolussi G, Tiribelli C. The role of ABC transporters in protecting cells from bilirubin toxicity. Curr Pharm Des 2009; 15(25): 2884–2892.
-
13.
Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: types, causes, clinical examinations, preventive measures and treatments: A narrative review article. Iran J Public Health 2016; 45(5): 558.
-
14.
Mitra S, Rennie J. Neonatal jaundice: Aetiology, diagnosis and treatment. Br J Hosp Med 2017; 78(12): 699–704.
-
15.
Roy-Chowdhury J, Roy-Chowdhury N, Jansen PL. Bilirubin metabolism and its disorders. In: Zakim and Boyer’s hepatology. Elsevier Inc.; 2006, p. 1449–1485.
-
16.
Kumar P, Murki S, Malik GK, Chawla D, Deorari AK, Karthi N, et al. Light-emitting diodes versus compact fluorescent tubes for phototherapy in neonatal jaundice: A multi-center randomized controlled trial. Indian Pediatr 2010; 47(2): 131–137.
-
17.
Keppler D. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab Dispos 2014; 42(4): 561–565.
-
18.
Singh A, Jialal I. Unconjugated hyperbilirubinemia 2019. In: StatPearls [Internet]. Treasure Island (FL). StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549796/.
-
19.
Balram C, Sabapathy K, Fei G, Khoo KS, Lee EJ. Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1* 28 is a common allele in Indians. Pharmacogenet Genomics 2002; 12(1): 81–83.
-
20.
Boo N-Y, Sin S, Chee S-C, Mohamed M, Ahluwalia AK, Ling MM-M, et al. Genetic factors and delayed TSB monitoring and treatment as risk factors associated with severe hyperbilirubinemia in term neonates admitted for phototherapy. J Trop Pediatr 2020; 66(6): 569–582.
-
21.
Huang M-J, Lin Y-C, Liu K, Chang P-F, Huang C-S. Effects of variation status and enzyme activity for UDP-glucuronosyltransferase 1A1 gene on neonatal hyperbilirubinemia. Pediatr Neonatol 2020; 61(5): 506–512.
-
22.
Leung AK, Sauve RS. Breastfeeding and breast milk jaundice. J R Soc Health 1989; 109(6): 213–217.
-
23.
Visentin M, Stieger B, Merz M, Kullak-Ublick GA. Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2. J Pharmacol Exp Ther 2015; 355(2): 145–151.
-
24.
Gondal B, Aronsohn A. Biliary interventions: A systematic approach to patients with jaundice. In: Seminars in interventional radiology. Thieme Medical Publishers; 2016, p. 253.
-
25.
Lapham K, Novak J, Marroquin LD, Swiss R, Qin S, Strock CJ, et al. Inhibition of hepatobiliary transport activity by the antibacterial agent fusidic acid: Insights into factors contributing to conjugated hyperbilirubinemia/cholestasis. Chem Res Toxicol 2016; 29(10): 1778–1788.
-
26.
Ma G, Zhang Y, Chen W, Tang Z, Xin X, Yang P, et al. Inhibition of human UGT1A1-mediated bilirubin glucuronidation by polyphenolic acids impact safety of popular salvianolic acid A/B-containing drugs and herbal products. Mol Pharm 2017; 14(9): 2952–2966.
-
27.
Chiddarwar AS, D’Silva SZ, Colah RB, Ghosh K, Mukherjee MB. Genetic variations in bilirubin metabolism genes and their association with unconjugated hyperbilirubinemia in adults. Ann Hum Genet 2017; 81(1): 11–19.
-
28.
Shad MA, Haq N, Tanzila R, Ahmad HB, Mazhar H. Diagnostic criteria and contributors to Gilbert’s syndrome. J Med Plants Res 2012; 6(28): 4467–4474.
-
29.
Wagner K-H, Shiels RG, Lang CA, Seyed Khoei N, Bulmer AC. Diagnostic criteria and contributors to Gilbert’s syndrome. Crit Rev Clin Lab Sci 2018; 55(2): 129–139.
-
30.
Lee C, Lee SM, Namgung R. Bilirubin metabolism and bilirubin encephalopathy. Neonatal Med 2013; 20(3): 268–275.
-
31.
Roca L, Calligaris S, Wennberg RP, Ahlfors CE, Malik SG, Ostrow JD, et al. Factors affecting the binding of bilirubin to serum albumins: Validation and application of the peroxidase method. Pediatr Res 2006; 60(6): 724–728.
-
32.
Andreu Y, Galbán J, de Marcos S, Castillo JR. Determination of direct-bilirubin by a fluorimetric-enzymatic method based on bilirubin oxidase. Fresenius J Anal Chem 2000; 368(5): 516–521.
-
33.
Westwood A. The analysis of bilirubin in serum. Ann Clin Biochem 1991; 28(2): 119–130.
-
34.
Klemm J, Prodromidis MI, Karayannis MI. An enzymic method for the determination of bilirubin using an oxygen electrode. Electroanal Int J Devoted Fundam Pract Asp Electroanal 2000; 12(4): 292–295.
-
35.
Birch MJ. Practical clinical biochemistry, Volume 1 by Varley H, Gowenlock AH, Bell M. London: Heinemann; 1980, pp 1277. Wiley Online Library; 1982.
-
36.
Laeeq A, Yasin M, Chaudhry AR. Transcutaneous bilirubinometry-clinical application. J-Pak Med Assoc 1993; 43: 28.
-
37.
McEwen M, Reynolds KJ. Noninvasive detection of bilirubin using pulsatile absorption. Australas Phys Eng Sci Med 2006; 29(1): 78–83.
-
38.
Adachi S, Uesugi T, Kamisaka K. Study of bilirubin metabolism by high-performance liquid chromatography: stability of bilirubin glucuronides. Arch Biochem Biophys 1985; 241(2): 486–493.
-
39.
Darch M. Role of the cytochrome P450 2A5 in bilirubin metabolism and clearance in C57BL/6 mice. [PhD Thesis]; 2016.
-
40.
Costarino AT, Ennever JF, Baumgart S, Speck WT, Paul M, Polin RA. Bilirubin photoisomerization in premature neonates under low-and high-dose phototherapy. Pediatrics 1985; 75(3): 519–522.
-
41.
Agati G, Fusi F, Pratesi S, Galvan P, Donzelli GP. Bilirubin photoisomerization products in serum and urine from a Crigler—Najjar type I patient treated by phototherapy. J Photochem Photobiol B 1998; 47(2–3): 181–189.
-
42.
Stephen AI, Ubwa ST, Igbum OG, Hati SS. Analytical methods comparison for the determination of bilirubin in blood samples of neonates. Adv Anal Chem 2017; 7(1): 1–6.
-
43.
Kazmierczak SC, Robertson AF, Catrou PG, Briley KP, Kreamer BL, Gourley GR. Direct spectrophotometric method for measurement of bilirubin in newborns: comparison with HPLC and an automated diazo method. Clin Chem 2002; 48(7): 1096–1097.
-
44.
Pichon J-BL, Riordan SM, Watchko J, Shapiro SM. The neurological sequelae of neonatal hyperbilirubinemia: definitions, diagnosis and treatment of the kernicterus spectrum disorders (KSDs). Curr Pediatr Rev 2017; 13(3): 199–209.
-
45.
Usman F, Diala UM, Shapiro S, LePichon J-B, Slusher TM. Acute bilirubin encephalopathy and its progression to kernicterus: current perspectives. Res Rep Neonatol 2018; 8: 33.
-
46.
Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005; 25(1): 54–59.
-
47.
van Imhoff DE, Cuperus FJ, Dijk PH, Tiribelli C, Hulzebos CV. Kernicterus, bilirubin induced neurological dysfunction and new treatments for unconjugated hyperbilirubinemia. In: Neonatology. Springer; 2012, p. 621–628.
-
48.
Onishi S, Isobe K, Itoh S, Manabe M, Sasaki K, Fukuzaki R, et al. Metabolism of bilirubin and its photoisomers in newborn infants during phototherapy. J Biochem (Tokyo) 1986; 100(3): 789–795.
-
49.
Rehak NN, Cecco SA, Hortin GL. Photolysis of bilirubin in serum specimens exposed to room lighting. Clin Chim Acta Int J Clin Chem 2008; 387(1–2): 181.
-
50.
Hansen TWR, Tommarello S. Effect of phenobarbital on bilirubin metabolism in rat brain. Neonatology 1998; 73(2): 106–111.
-
51.
Soltys PJ, Mullon C, Langer R. Oral treatment for jaundice using immobilized bilirubin oxidase. Artif Organs 1992; 16(4): 331–335.
-
52.
Shad MA, Nawaz H, Rehman T, Ikram N, others. Determination of some biochemicals, phytochemicals and antioxidant properties of different parts of Cichorium intybus L.: A comparative study. J Anim Plant Sci 2013; 23(4): 1060–1066.
-
53.
Moghadamtousi SZ, Fadaeinasab M, Nikzad S, Mohan G, Ali HM, Kadir HA. Annona muricata (Annonaceae): A review of its traditional uses, isolated acetogenins and biological activities. Int J Mol Sci 2015; 16(7): 15625–15658.
-
54.
Zhang L, Yuan B, Wang H, Gao Y. Therapeutic effect of Agaricus brasiliensis on phenylhydrazine-induced neonatal jaundice in rats. BioMed Res Int 2015; 2015.
-
55.
Abbasi AM, Khan MA, Ahmad M, Zafar M, Khan H, Muhammad N, et al. Medicinal plants used for the treatment of jaundice and hepatitis based on socio-economic documentation. Afr J Biotechnol 2009; 8(8).
-
56.
Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 2004; 144(5): 626–631.
-
57.
Badiee Z. Exchange transfusion in neonatal hyperbilirubinaemia: Experience in Isfahan, Iran. Singapore Med J 2007; 48(5): 421.
-
58.
Murki S, Kumar P. Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. In: Seminars in perinatology. Elsevier; 2011. p. 175–184.
-
59.
Bambauer R, El-Saadi R, Graf N, Jesberger HJ, Limbach HG, Cordes H. Plasmapheresis in newborns with hyperbilirubinemia. Artif Organs 1992; 16(5): 472–476.
-
60.
Keklik M, Sivgin S, Kaynar L, Pala C, Solmaz M, Cetin M, et al. Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: a single center experience. Transfus Apher Sci 2013; 48(3): 323–326.
-
61.
Broux B, Lefère L, Deprez P, van Loon G. Plasma exchange as a treatment for hyperbilirubinemia in 2 foals with neonatal isoerythrolysis. J Vet Intern Med 2015; 29(2): 736.
-
62.
Schauer R, Lang T, Zimmermann A, Stangl M, Da Silva L, Schildberg FW, et al. Successful liver transplantation of two brothers with crigler-najjar syndrome type 1 using a single cadaveric organ. Transplantation 2002; 73(1): 67–69.
-
63.
Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 2006; 29(2): 431–435.
-
64.
Roy-Chowdhury N, Kadakol A, Sappal BS, Thummala NR, Ghosh SS, Lee S-W, et al. Gene therapy for inherited hyperbilirubinemias. J Perinatol 2001; 21(1): S114–S118.
-
65.
van Dijk R, Beuers U, Bosma PJ. Gene replacement therapy for genetic hepatocellular jaundice. Clin Rev Allergy Immunol 2015; 48(2–3): 243–253.
-
66.
Arnolda G, Chien TD, Hayen A, Hoi NTX, Maningas K, Joe P, et al. A comparison of the effectiveness of three LED phototherapy machines, single-and double-sided, for treating neonatal jaundice in a low resource setting. PLoS One 2018; 13(10): e0205432.
-
67.
Montealegre A, Charpak N, Parra A, Devia C, Coca I, Bertolotto AM. Effectiveness and safety of two phototherapy devices for the humanised management of neonatal jaundice. An Pediatría Engl Ed 2020; 92(2): 79-87.
-
68.
Ergaz Z, Arad I. Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice. J Perinat Med-Off J WAPM 1993; 21(3): 183–187.
-
69.
Alpay F, Sarici SU, Okutan V, Erdem G, Özcan O, Gökçay E. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999; 88(2): 216–219.
-
70.
Girish G, Chawla D, Agarwal R, Paul VK, Deorari AK. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn–a randomized controlled trial. Indian Pediatr 2008; 45(8): 653.
-
71.
Demirel G, Akar M, Celik IH, Erdeve O, Uras N, Oguz SS, et al. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates. Int J Hematol 2011; 93(6): 700–703.
-
72.
Schulz S, Wong RJ, Vreman HJ, Strevenson DK. Metalloporphyrins–an update. Front Pharmacol 2012; 3: 68.
-
73.
Fujioka K, Kalish F, Wong RJ, Stevenson DK. Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model. Pediatr Res 2016; 79(2): 251–257.
-
74.
Maisels MJ, Yang H. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility. J Perinatol 2012; 32(11): 899–900.
-
75.
Fallah R, Islami Z, Lotfi SR. Single dose of 50 mg/kg clofibrate in jaundice of healthy term neonates: Randomised clinical trial of efficacy and safety. Indian J Pediatr 2012; 79(2): 194–197.
-
76.
Al-Banna SM, Riad AN, Anis SS. The effect of fenofibrate and antioxidant vitamins [D, E and C] in treatment of uncomplicated neonatal hyperbilirubinemia. Ann Neonatol J 2020; 2(1): 37–48.
-
77.
Quidde J, Azémar M, Bokemeyer C, Arnold D, Stein A. Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: A case series and review of literature. Ther Adv Med Oncol 2016; 8(3): 144–152.
-
78.
Wu R, Feng S, Han M, Caldwell P, Liu S, Zhang J, et al. Yinzhihuang oral liquid combined with phototherapy for neonatal jaundice: A systematic review and meta-analysis of randomized clinical trials. BMC Complement Altern Med 2018; 18(1): 228.
-
79.
Faal G, Masjedi HK, Sharifzadeh G, Kiani Z. Efficacy of zinc sulfate on indirect hyperbilirubinemia in premature infants admitted to neonatal intensive care unit: A double-blind, randomized clinical trial. BMC Pediatr 2020; 20(1): 1–7.
-
80.
Kassem LM, Abdelrahim M, Naguib HF. Investigating the efficacy and safety of silymarin in management of hyperbilirubinemia in neonatal jaundice. Med Sci 2013; 2(2): 575–590.
-
81.
Lei M, Liu T, Li Y, Liu Y, Meng L, Jin C. Effects of massage on newborn infants with jaundice: A meta-analysis. Int J Nurs Sci 2018; 5(1): 89–97.
-
82.
Wang L, Shuai T, Wang Y-Y, Cao H. The effect of traditional Chinese medicine washing combined with massage for neonatal jaundice: A meta-analysis. TMR Integr Nurs 2018; 1(2): 36–44.
-
83.
Slusher TM, Olusanya BO, Vreman HJ, Wong RJ, Brearley AM, Vaucher YE, et al. Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial. Trials 2013; 14(1): 446.
-
84.
Negi R, Sorte DY, Gomati B. Effect of white reflecting curtains on neonatal jaundice. Int J Nurs Educ 2015; 7(4): 147–152.
-
85.
Pratesi S, Di Fabio S, Bresci C, Di Natale C, Bar S, Dani C. Broad-spectrum light versus blue light for phototherapy in neonatal hyperbilirubinemia: A randomized controlled trial. Am J Perinatol 2015; 32(08): 779–784.
-
86.
Zeng J, Wang S, Li Y, Li H, Luo Q, Huang Y, et al. Yinzhihuang oral liquid in the treatment of neonatal jaundice: A meta-analysis. Pharm Biol 2017; 55(1): 554–559.
-
87.
Beiranvand S, Hosseinabadi R, Firouzi M, Almasian M, Anbari K. Impact of combined oral zinc sulfate and phototherapy on serum bilirubin levels in the term neonates with jaundice. Iran J Neonatol IJN 2018; 9(3): 20–25.
-
88.
Boskabadi H, Mollaei MK, Zakerihamidi M, Mobarhan MG, Bagheri F. The effect of exchange transfusion on prooxidant-antioxidant balance in newborns Jaundice. Biomed Res Ther 2018; 5: 2119–2129.
-
89.
Colbourn T, Mwansambo C. Sunlight phototherapy for neonatal jaundice—time for its day in the sun? Lancet Glob Health 2018; 6(10): e1052–e1053.
-
90.
Thakkar D, Verma A, Malgorzata R. G11 Phototherapy at home for the treatment of neonatal jaundice: An innovative, patient centered pilot project. Arch Dis Child 2019; 104(Suppl 2): A5.
-
91.
Abdel-Aziz Ali SM, Mansour Galal S, Sror SM, Hussein O, Abd-El-Haseeb Ahmed A-E-HO, Hamed EA. Efficacy of oral agar in management of indirect hyperbilirubinemia in full-term neonates. J Matern Fetal Neonatal Med 2020; 1–6.
-
92.
Nizam MA, Alvi AS, Hamdani MM, Lalani AS, Sibtain SA, Bhangar NA. Efficacy of double versus single phototherapy in treatment of neonatal jaundice: A meta-analysis. Eur J Pediatr 2020; 179(6): 865–874.
-
93.
Rahideh ST, Saadati A, Rahmati N, Azadeh F, Janani L, Shidfar F. The effect of vitamin C supplementation in the last month of pregnancy on neonatal bilirubin levels; A double-blind randomized clinical trial. Complement Ther Med 2020; 102359.
Editor-in-Chief
László ROSIVALL (Semmelweis University, Budapest, Hungary)
Managing Editor
Anna BERHIDI (Semmelweis University, Budapest, Hungary)
Co-Editors
- Gábor SZÉNÁSI (Semmelweis University, Budapest, Hungary)
- Ákos KOLLER (Semmelweis University, Budapest, Hungary)
- Zsolt RADÁK (University of Physical Education, Budapest, Hungary)
- László LÉNÁRD (University of Pécs, Hungary)
- Zoltán UNGVÁRI (Semmelweis University, Budapest, Hungary)
Assistant Editors
- Gabriella DÖRNYEI (Semmelweis University, Budapest, Hungary)
- Zsuzsanna MIKLÓS (Semmelweis University, Budapest, Hungary)
- György NÁDASY (Semmelweis University, Budapest, Hungary)
Hungarian Editorial Board
- György BENEDEK (University of Szeged, Hungary)
- Zoltán BENYÓ (Semmelweis University, Budapest, Hungary)
- Mihály BOROS (University of Szeged, Hungary)
- László CSERNOCH (University of Debrecen, Hungary)
- Magdolna DANK (Semmelweis University, Budapest, Hungary)
- László DÉTÁRI (Eötvös Loránd University, Budapest, Hungary)
- Zoltán GIRICZ (Semmelweis University, Budapest, Hungary and Pharmahungary Group, Szeged, Hungary)
- Zoltán HANTOS (Semmelweis University, Budapest and University of Szeged, Hungary)
- Zoltán HEROLD (Semmelweis University, Budapest, Hungary)
- László HUNYADI (Semmelweis University, Budapest, Hungary)
- Gábor JANCSÓ (University of Pécs, Hungary)
- Zoltán KARÁDI (University of Pecs, Hungary)
- Miklós PALKOVITS (Semmelweis University, Budapest, Hungary)
- Gyula PAPP (University of Szeged, Hungary)
- Gábor PAVLIK (University of Physical Education, Budapest, Hungary)
- András SPÄT (Semmelweis University, Budapest, Hungary)
- Gyula SZABÓ (University of Szeged, Hungary)
- Zoltán SZELÉNYI (University of Pécs, Hungary)
- Lajos SZOLLÁR (Semmelweis University, Budapest, Hungary)
- József TOLDI (MTA-SZTE Neuroscience Research Group and University of Szeged, Hungary)
- Árpád TÓSAKI (University of Debrecen, Hungary)
International Editorial Board
- Dragan DJURIC (University of Belgrade, Serbia)
- Christopher H. FRY (University of Bristol, UK)
- Stephen E. GREENWALD (Blizard Institute, Barts and Queen Mary University of London, UK)
- Tibor HORTOBÁGYI (University of Groningen, Netherlands)
- George KUNOS (National Institutes of Health, Bethesda, USA)
- Massoud MAHMOUDIAN (Iran University of Medical Sciences, Tehran, Iran)
- Tadaaki MANO (Gifu University of Medical Science, Japan)
- Luis Gabriel NAVAR (Tulane University School of Medicine, New Orleans, USA)
- Hitoo NISHINO (Nagoya City University, Japan)
- Ole H. PETERSEN (Cardiff University, UK)
- Ulrich POHL (German Centre for Cardiovascular Research and Ludwig-Maximilians-University, Planegg, Germany)
- Andrej A. ROMANOVSKY (University of Arizona, USA)
- Anwar Ali SIDDIQUI (Aga Khan University, Karachi, Pakistan)
- Csaba SZABÓ (University of Fribourg, Switzerland)
- Eric VICAUT (Université de Paris, UMRS 942 INSERM, France)
Editorial Correspondence:
Physiology International
Semmelweis University
Faculty of Medicine, Institute of Translational Medicine
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: pi@semmelweis.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- EMBASE/Excerpta Medica
- Global Health
- Index Copernicus
- Index Medicus
- Medline
- Referativnyi Zhurnal
- SCOPUS
- WoS - Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 2.2 |
| Rank by Impact Factor | Q3 (Physiology) |
| Journal Citation Indicator | 0.58 |
| Scopus | |
| CiteScore | 3.4 |
| CiteScore rank | Q2 (Physical Therapy, Sports Therapy and Rehabilitation) |
| SNIP | 0.508 |
| Scimago | |
| SJR index | 0.407 |
| SJR Q rank | Q2 |
| Physiology International | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article |
| Printed Color Illustrations | 40 EUR (or 10 000 HUF) + VAT / piece |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 752 EUR / 828 USD Print + online subscription: 880 EUR / 968 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Physiology International | |
|---|---|
| Language | English |
| Size | B5 |
| Year of Foundation |
2006 (1950) |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 2498-602X (Print) |
| ISSN | 2677-0164 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Oct 2024 | 274 | 1 | 2 |
| Nov 2024 | 138 | 0 | 0 |
| Dec 2024 | 135 | 1 | 1 |
| Jan 2025 | 163 | 0 | 0 |
| Feb 2025 | 166 | 1 | 2 |
| Mar 2025 | 142 | 0 | 0 |
| Apr 2025 | 0 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.